Form 4: RVP CEO Buys Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Retractable Technologies Inc. CEO Thomas J. Shaw purchased 9,042 shares of common stock at $0.7963 per share under a pre-arranged 10b5-1 plan.

Summary

  • Thomas J. Shaw, President and CEO, Director, and 10% Owner of Retractable Technologies Inc. (RVP), acquired 9,042 shares of common stock.
  • The transaction occurred on August 19, 2025, at a weighted average price of $0.7963 per share.
  • This purchase was made pursuant to a Rule 10b5-1 trading plan adopted on August 22, 2024.
  • Following the transaction, Mr. Shaw directly owns 15,645,325 shares and indirectly owns 831,600 shares.
  • Indirect ownership includes 500,000 shares held as Trustee for the benefit of a family member, with voting control over the remainder of indirect shares pursuant to a voting agreement.

Sentiment

Score: 7

Explanation: The President and CEO's purchase of shares, even under a pre-arranged plan, generally signals confidence in the company's future prospects and valuation.

Positives

  • The President and CEO, Thomas J. Shaw, increased his direct ownership in the company by purchasing 9,042 shares.
  • Insider buying, even under a pre-arranged plan, can signal management's confidence in the company's future prospects and valuation.

Negatives

  • No explicit negative information is disclosed in this transaction report.

Risks

  • This filing, a Form 4, does not detail specific company risks.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance.

Management Comments

  • The purchase of shares by the President and CEO, Thomas J. Shaw, under a pre-arranged 10b5-1 plan, indicates a planned increase in his stake in the company.

Industry Context

This filing reports an insider transaction and does not provide broader industry context or trends.

Comparison to Industry Standards

  • This filing is a Form 4 reporting an insider transaction and does not contain information for comparison to industry standards or specific comparable companies/projects.

Related Party Transactions

  • Thomas J. Shaw has indirect beneficial ownership of 500,000 shares as Trustee for the benefit of a family member, and voting control over additional shares pursuant to a voting agreement.

Stakeholder Impact

  • Shareholders may view the CEO's purchase of additional shares as a positive signal of management's confidence in the company's value and future performance.

Next Steps

  • This Form 4 filing does not specify future actions, events, or milestones.

Key Dates

DateDescription
August 22, 2024Date of adoption of the Rule 10b5-1 Plan.
08/19/2025Date of common stock acquisition by Thomas J. Shaw.
08/20/2025Date the Form 4 was signed.

Recommendation

hold

The purchase of shares by the President and CEO, Thomas J. Shaw, under a pre-arranged Rule 10b5-1 plan, indicates a planned increase in his stake. While insider buying can signal confidence, this specific transaction is part of a pre-scheduled plan rather than a discretionary open market purchase, suggesting a neutral to slightly positive signal for immediate investment decisions. Investors should consider this in conjunction with broader financial performance and market conditions.

Keywords

RVP, Retractable Technologies, insider trading, Form 4, CEO stock purchase, Thomas J. Shaw, 10b5-1 plan, medical devices, healthcare

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.